{"id":5887,"date":"2022-03-14T13:23:28","date_gmt":"2022-03-14T12:23:28","guid":{"rendered":"https:\/\/www.rapharm.eu\/en\/?page_id=5887"},"modified":"2022-03-25T10:27:19","modified_gmt":"2022-03-25T09:27:19","slug":"news","status":"publish","type":"page","link":"https:\/\/www.rapharm.eu\/en\/news\/","title":{"rendered":"News"},"content":{"rendered":"<style type=\"text\/css\"> \n#cmsms_row_6a7f37f4dba7e .cmsms_row_outer_parent { \n\tpadding-top: 70px; \n} \n\n#cmsms_row_6a7f37f4dba7e .cmsms_row_outer_parent { \n\tpadding-bottom: 60px; \n} \n\n<\/style><div id=\"cmsms_row_6a7f37f4dba7e\" class=\"cmsms_row cmsms_color_scheme_default\">\n<div class=\"cmsms_row_outer_parent\">\n<div class=\"cmsms_row_outer\">\n<div class=\"cmsms_row_inner\">\n<div class=\"cmsms_row_margin\">\n<div class=\"cmsms_column one_first\">\n<div class=\"cmsms_wrap_blog entry-summary\" id=\"blog_6a7f37f4dbba9\"><div class=\"blog standard\">\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6230\" class=\"cmsms_default_type post-6230 post type-post status-publish format-standard hentry category-novice-en\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/en\/eu-new-limitation-of-ingredients-in-food-supplements\/\">EU: New limitation of ingredients in food supplements<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">On <abbr class=\"published\" title=\"03\/01\/2023\">03\/01\/2023<\/abbr><abbr class=\"dn date updated\" title=\"18\/04\/2023\">18\/04\/2023<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>In connection with Article 8(2) of Regulation (EC) no. 1925\/2006, the Commission adopted Regulation no. 2022\/2340, which restricts the use...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/en\/eu-new-limitation-of-ingredients-in-food-supplements\/\">Read More<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6218\" class=\"cmsms_default_type post-6218 post type-post status-publish format-standard hentry category-novice-en category-uncategorized\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/en\/eu-two-new-guidelines-have-been-published-and-approved-by-the-mdcg\/\">EU: Two new guidelines have been published and approved by the MDCG<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">On <abbr class=\"published\" title=\"27\/10\/2022\">27\/10\/2022<\/abbr><abbr class=\"dn date updated\" title=\"27\/10\/2022\">27\/10\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>On 14 September, two new guidelines, MDCG 2022-15 and MDCG 2021-22, were published on the website of the European Commission...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/en\/eu-two-new-guidelines-have-been-published-and-approved-by-the-mdcg\/\">Read More<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6208\" class=\"cmsms_default_type post-6208 post type-post status-publish format-standard hentry category-novice-en\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/en\/eu-beauty-claims-vs-health-claims-on-foods\/\">EU: Beauty claims vs. health claims on foods<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">On <abbr class=\"published\" title=\"18\/10\/2022\">18\/10\/2022<\/abbr><abbr class=\"dn date updated\" title=\"03\/02\/2023\">03\/02\/2023<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>In the last years, there has been an increase in fortified foods and food supplements that primarily target the female...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/en\/eu-beauty-claims-vs-health-claims-on-foods\/\">Read More<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6194\" class=\"cmsms_default_type post-6194 post type-post status-publish format-standard hentry category-novice-en category-uncategorized\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/en\/eu-on-4-july-2022-the-european-commission-accepted-implementing-regulation-2022-1107-laying-down-common-specifications-for-certain-class-d-in-vitro-diagnostic-medical-devices-ivds-in-accordance-wi\/\">EU: On 4 July 2022, the European Commission accepted Implementing Regulation 2022\/1107 laying down common specifications for certain class D in vitro diagnostic medical devices (IVDs) in accordance with Regulation (EU) 2017\/746<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">On <abbr class=\"published\" title=\"08\/07\/2022\">08\/07\/2022<\/abbr><abbr class=\"dn date updated\" title=\"11\/07\/2022\">11\/07\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>In the document European Commission explains that for certain class D IVDs harmonised standards do not exist and since the...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/en\/eu-on-4-july-2022-the-european-commission-accepted-implementing-regulation-2022-1107-laying-down-common-specifications-for-certain-class-d-in-vitro-diagnostic-medical-devices-ivds-in-accordance-wi\/\">Read More<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6184\" class=\"cmsms_default_type post-6184 post type-post status-publish format-standard hentry category-novice-en category-uncategorized\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/en\/eu-mdcg-position-paper-has-been-published\/\">EU: MDCG Position paper has been published<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">On <abbr class=\"published\" title=\"21\/06\/2022\">21\/06\/2022<\/abbr><abbr class=\"dn date updated\" title=\"21\/06\/2022\">21\/06\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>In June, a Position paper MDCG 2022-11 was published on the website of the European Commission and approved by the...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/en\/eu-mdcg-position-paper-has-been-published\/\">Read More<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6176\" class=\"cmsms_default_type post-6176 post type-post status-publish format-standard hentry category-novice-en category-uncategorized\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/en\/eu-new-guideline-has-been-published-and-approved-by-the-mdcg\/\">EU: New guideline has been published and approved by the MDCG<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">On <abbr class=\"published\" title=\"17\/06\/2022\">17\/06\/2022<\/abbr><abbr class=\"dn date updated\" title=\"17\/06\/2022\">17\/06\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>In May, a new guideline, MDCG 2022-8 was published on the website of the European Commission and approved by the...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/en\/eu-new-guideline-has-been-published-and-approved-by-the-mdcg\/\">Read More<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6166\" class=\"cmsms_default_type post-6166 post type-post status-publish format-standard hentry category-novice-en category-uncategorized\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/en\/eu-evaluation-of-cannabidiol-cbd-as-a-novel-food-suspended\/\">EU: Evaluation of cannabidiol (CBD) as a novel food suspended<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">On <abbr class=\"published\" title=\"15\/06\/2022\">15\/06\/2022<\/abbr><abbr class=\"dn date updated\" title=\"15\/06\/2022\">15\/06\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>The European Food Safety Authority (EFSA) currently suspending the evaluation of CBD as a novel food, as current scientific documentation...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/en\/eu-evaluation-of-cannabidiol-cbd-as-a-novel-food-suspended\/\">Read More<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6153\" class=\"cmsms_default_type post-6153 post type-post status-publish format-standard hentry category-novice-en category-uncategorized\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/en\/6153\/\">EU: New guideline has been published and approved by the MDCG<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">On <abbr class=\"published\" title=\"07\/06\/2022\">07\/06\/2022<\/abbr><abbr class=\"dn date updated\" title=\"08\/06\/2022\">08\/06\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>In May, a new guideline, MDCG 2022-8 was published on the website of the European Commission and approved by the...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/en\/6153\/\">Read More<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6138\" class=\"cmsms_default_type post-6138 post type-post status-publish format-standard hentry category-novice-en category-uncategorized\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/en\/eu-joint-implementation-and-preparedness-plan-for-ivdr-2\/\">EU: Status of the EU-Switzerland Mutual Recognition Agreement (MRA) for in vitro diagnostic medical devices<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">On <abbr class=\"published\" title=\"06\/06\/2022\">06\/06\/2022<\/abbr><abbr class=\"dn date updated\" title=\"06\/06\/2022\">06\/06\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>Switzerland participates in the internal market of the European Union through the Agreement on Mutual Recognition in relation to conformity...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/en\/eu-joint-implementation-and-preparedness-plan-for-ivdr-2\/\">Read More<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6129\" class=\"cmsms_default_type post-6129 post type-post status-publish format-standard hentry category-novice-en category-uncategorized\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/en\/eu-new-harmonized-standards-for-mdr-and-ivdr-regulation-have-been-published\/\">EU: New harmonized standards for MDR and IVDR regulation have been published<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">On <abbr class=\"published\" title=\"27\/05\/2022\">27\/05\/2022<\/abbr><abbr class=\"dn date updated\" title=\"27\/05\/2022\">27\/05\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>In May 2022, Commission Implementing Decisions (EU) 2022\/757 on new harmonized standards for MDR and 2022\/729 on new harmonized standards...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/en\/eu-new-harmonized-standards-for-mdr-and-ivdr-regulation-have-been-published\/\">Read More<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6095\" class=\"cmsms_default_type post-6095 post type-post status-publish format-standard hentry category-novice-en category-uncategorized\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/en\/eu-objavljeni-sta-dve-novi-smernici-ki-jih-je-potrdila-mdcg\/\">EU: Two new guidelines have been published and approved by the MDCG<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">On <abbr class=\"published\" title=\"12\/05\/2022\">12\/05\/2022<\/abbr><abbr class=\"dn date updated\" title=\"16\/05\/2022\">16\/05\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>Recently, two new guidelines, MDCG 2022-5 and MDCG 2022-6, were published on the website of the European Commission and approved...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/en\/eu-objavljeni-sta-dve-novi-smernici-ki-jih-je-potrdila-mdcg\/\">Read more<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6074\" class=\"cmsms_default_type post-6074 post type-post status-publish format-standard hentry category-novice-en\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/en\/eu-leto-2022-je-poleg-zacetka-veljavnosti-prej-pripravljenih-delov-zakonodaje-na-podrocju-zdravil-zaznamovano-s-pripravami-na-spremembe-splosne-regulative-na-podrocju-zdravil\/\">EU: In addition to the entry into force of previously prepared parts of legislation in the field of medicines, 2022 is marked by preparations for changes to the general regulations in the field of medicines<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">On <abbr class=\"published\" title=\"03\/05\/2022\">03\/05\/2022<\/abbr><abbr class=\"dn date updated\" title=\"12\/05\/2022\">12\/05\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>On 28 January 2022 new legislation in the field of veterinary medicines, entered into force, which aims to adapt regulations...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/en\/eu-leto-2022-je-poleg-zacetka-veljavnosti-prej-pripravljenih-delov-zakonodaje-na-podrocju-zdravil-zaznamovano-s-pripravami-na-spremembe-splosne-regulative-na-podrocju-zdravil\/\">Read More<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n<\/div><div class=\"cmsms_wrap_more_posts\"><div class=\"cmsms_wrap_pagination\"><ul class='page-numbers'>\n\t<li><span aria-current=\"page\" class=\"page-numbers current\">1<\/span><\/li>\n\t<li><a class=\"page-numbers\" href=\"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/pages\/5887\/page\/2\/\">2<\/a><\/li>\n\t<li><a class=\"next page-numbers\" href=\"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/pages\/5887\/page\/2\/\"><span class=\"cmsms_theme_icon_slide_next\"><\/span><\/a><\/li>\n<\/ul>\n<\/div><\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-5887","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>News - raPHARM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rapharm.eu\/novice\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News - raPHARM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rapharm.eu\/novice\/\" \/>\n<meta property=\"og:site_name\" content=\"raPHARM\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-25T09:27:19+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rapharm.eu\/novice\/\",\"url\":\"https:\/\/www.rapharm.eu\/novice\/\",\"name\":\"News - raPHARM\",\"isPartOf\":{\"@id\":\"https:\/\/www.rapharm.eu\/#website\"},\"datePublished\":\"2022-03-14T12:23:28+00:00\",\"dateModified\":\"2022-03-25T09:27:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.rapharm.eu\/novice\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rapharm.eu\/novice\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.rapharm.eu\/novice\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.rapharm.eu\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rapharm.eu\/#website\",\"url\":\"https:\/\/www.rapharm.eu\/\",\"name\":\"raPHARM\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rapharm.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"News - raPHARM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rapharm.eu\/novice\/","og_locale":"en_US","og_type":"article","og_title":"News - raPHARM","og_url":"https:\/\/www.rapharm.eu\/novice\/","og_site_name":"raPHARM","article_modified_time":"2022-03-25T09:27:19+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rapharm.eu\/novice\/","url":"https:\/\/www.rapharm.eu\/novice\/","name":"News - raPHARM","isPartOf":{"@id":"https:\/\/www.rapharm.eu\/#website"},"datePublished":"2022-03-14T12:23:28+00:00","dateModified":"2022-03-25T09:27:19+00:00","breadcrumb":{"@id":"https:\/\/www.rapharm.eu\/novice\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rapharm.eu\/novice\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rapharm.eu\/novice\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rapharm.eu\/en\/"},{"@type":"ListItem","position":2,"name":"News"}]},{"@type":"WebSite","@id":"https:\/\/www.rapharm.eu\/#website","url":"https:\/\/www.rapharm.eu\/","name":"raPHARM","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rapharm.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/pages\/5887","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/comments?post=5887"}],"version-history":[{"count":5,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/pages\/5887\/revisions"}],"predecessor-version":[{"id":5946,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/pages\/5887\/revisions\/5946"}],"wp:attachment":[{"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/media?parent=5887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}